Business Description
Q32 Bio Inc
NAICS : 541714
SIC : 2833
ISIN : US7469641051
Description
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.72 | |||||
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 0.41 | |||||
Debt-to-EBITDA | -0.5 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | -0.59 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 11.29 | |||||
9-Day RSI | 18.26 | |||||
14-Day RSI | 25.41 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.19 | |||||
Quick Ratio | 4.19 | |||||
Cash Ratio | 4.11 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -20.27 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | 277.26 | |||||
Net Margin % | 177.59 | |||||
FCF Margin % | 172.32 | |||||
ROA % | -30.86 | |||||
ROIC % | -93.9 | |||||
ROC (Joel Greenblatt) % | -502.99 | |||||
ROCE % | -90.84 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 3.79 | |||||
Price-to-Tangible-Book | 3.79 | |||||
EV-to-EBIT | -1.72 | |||||
EV-to-EBITDA | -1.73 | |||||
EV-to-Revenue | -4.76 | |||||
EV-to-FCF | -2.76 | |||||
Price-to-Net-Current-Asset-Value | 5.36 | |||||
Price-to-Net-Cash | 5.82 | |||||
Earnings Yield (Greenblatt) % | -58.14 | |||||
FCF Yield % | -13.66 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:QTTB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Q32 Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | -14.662 | ||
EPS (TTM) ($) | -2.183 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 25.41 | ||
14-Day ATR ($) | 1.777724 | ||
20-Day SMA ($) | 21.9005 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 15.07 - 32.88 | ||
Shares Outstanding (Mil) | 11.94 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Q32 Bio Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Q32 Bio Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Q32 Bio Inc Frequently Asked Questions
What is Q32 Bio Inc(QTTB)'s stock price today?
The current price of QTTB is $15.49. The 52 week high of QTTB is $32.88 and 52 week low is $15.07.
When is next earnings date of Q32 Bio Inc(QTTB)?
The next earnings date of Q32 Bio Inc(QTTB) is 2024-08-30 Est..
Does Q32 Bio Inc(QTTB) pay dividends? If so, how much?
Q32 Bio Inc(QTTB) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |